Arch Therapeutics Inc (ARTH)

[formerdtrader]

THe way I see it is Kudos for the company for actually coming through with 2 major promises for a novel treatment - FDA approval in US and CE Mark in Europe.

The two biggest obstacles have been overcome.

Now, getting the partner to manufacture or (possibly a buyout of the company) is inevitable, even if it is 3-12 months off due to COVID.

It at least stops the bleeding and reaffirms that Norchi and his team are putting everything they have into making this a real company that can actually produce revenue and profits in the future.

I am definitely now in for the long run (have been in for 4 years :) so a couple of months is not going to bother me)

Adding more.